Page 176 - ASHG 2012 Annual Meeting Program Guide

POSTER SESSIONS
165
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
structured populations.
E. Kang, N. Furlotte, B. Han, J.
Joo, R. Davis, A. Lusis, E. Eskin.
1338
T Comparison of rare variant tests.
J. Lihm, E. J.
Yoon, H. Wu, T. Harris, C. Wong, J. Ceris, J. Weisburd, N.
R. Mendell, W. Kim, K. Ahn, D. Gordon, S. J. Finch.
1339
F Artificial intelligence analysis of prostate cancer
susceptibility using a pareto-optimized computational
evolution system.
J. H. Moore, D. P. Hill, A. Sulovari, L.
Kidd.
1340
W A simple Bayesian method for modeling effect
heterogenity across genetic studies.
C. C. A. Spencer,
P. J. Donnelly, M. Pirinen.
1341
T Effectively identifying and characterizing eQTLs
from multiple tissues using a meta-analytic approach.
J. Sul, B. Han, C. Ye, T. Choi, E. Eskin.
1342
F
PEDF
gene polymorphism (p.Met72Thr) analysis
in diabetic retinopathy cases.
S. Passan, V. Vanita.
1343
W Chromosome 10 gene may be associated to
response to
Leishmania
antigens.
L. Pereira, J. Pescarini,
R. Ferreira, L. M. Camargo, H. Krieger, L. M. Garrido.
1344
T Genetic associations with essential amino acids
in infants with patent ductus arteriosus.
K. K. Ryckman,
J. M. Dagle, O. A. Shchelochkov, S. L. Berberich, J. C.
Murray.
1345
F Low frequency SNPs are associated with
congenital and severe clinical phenotypes in an
eectronic medical record.
J. D. Mosley, D. M. Roden, J.
D. Denny.
1346
W Rare variant testing for meta-analysis and
survival analysis.
H. Chen, T. Lumley, J. Dupuis, J. Brody,
A. Morrison, B. Cornes, D. J. Lybarger, B. Davis, C. Sitlani,
D. Siscovick, J. B. Meigs, L. A. Cupples.
1347
T Selection of sequence variants for quantitative
traits using penalized regression: Using LASSO, LARS
and elastic net in the tiled regression framework.
Y.
Kim, B. Suktitipat, A. J. M. Sorant, A. F. Wilson.
1348
F Identification of genome-wide SNPs that are
informative for individual genetic heritage in the family
investigation of nephropathy and diabetes.
R. C.
Williams, FIND Research Group.
1349
W Testing copy number variant/trait associations
detected using Manhattan plots.
G. A. Satten, D.
Ramachandran, J. G. Mulle, A. S. Allen, L. J. H. Bean, C.
Maslen, S. L. Sherman, R. H. Reeves, M. E. Zwick.
1350
T A novel collapsing method for rare copy number
variants.
J. P. Szatkiewicz, P. F. Sullivan, J. Y. Tzeng.
1351
F A pseudo-score-based meta-analysis in genetic
association studies: Application to Mayo Genome
Consortia data.
E. Ryu, R. E. Gullerud, P. A. Decker, J.
Pathak, P. J. Limburg, S. J. Bielinski.
de novo and recent mutations in population-based
exome-sequencing studies.
N. Solovieff, M. Fromer, D.
Ruderfer, J. Moran, K. Chambert, C. Hultman, P. Sullivan,
H. Williams, E. Rees, P. Gormley, A. Palotie, G. Kirov, M.
Owen, M. O’Donovan, P. Sklar, S. McCarroll, S. Purcell.
1326
T Mitochondrial DNA polymorphism 13704 (C/T)
might induce hematologic malignancy predisposition
in Turkish population.
N. Duzkale, A. Tatar.
1327
F Significant association of
LPL
polymorphisms
with HDL- cholesterol level in Tongan adults.
I. Naka, R.
Kimura, T. Inaoka, Y. Matsumura, J. Ohashi.
1328
W Personalized risk prediction for prostate cancer
according to specific family history.
L. Cannon-Albright,
F. Albright, W. Lowrance, R. Stephenson.
1329
T Estimating disease risk from environmental
and genetic factors to motivate behavioral changes.
C. M. Lewis, J. M. Yarnall, G. H. M. Goddard, D. J. M.
Crouch.
1330
F Improving celiac disease risk prediction by
testing non-HLA variants additional to HLA variants.
J. Romanos, A. Rosen, V. Kumar, G. Trynka, L. Franke,
A. Szperl, J. Gutierrez-Achury, C. C. van Diemen,
R. Kanninga, S. A. Jankipersadsing, A. K. Steck, G.
Eisenbarth, D. A. van Heel, B. Cukrowska, V. Bruno, M. C.
Mazzilli, C. Nunez, J. R. Bilbao, M. L. Mearin, D. Barisani,
M. Rewers, J. Norris, A. Ivarsson, H. M. Boezen, E. Liu, C.
Wijmenga, PreventCD Group.
1331
W Bayesian polygenic prediction of myocardial
infarction risk and lipid levels.
B. Vilhjalmsson, R. Do,
E. A. Stahl, B. Pasaniuc, S. Pollack, N. Zaitlen, J. Yang,
M. E. Goddard, P. M. Visscher, P. Kraft, N. Patterson, S.
Kathiresan, A. L. Price.
1332
T Testing for the presence of liability models.
C.
Herold, T. Vaitsiakhovich, T. Becker.
1333
F Alcohol and aldehyde dehydrogenase
polymorphisms and blood pressure elevation in
Japanese over 20 years.
M. Isomura, T. Wang, Y.
Yoshida, T. Nabika.
1334
W The
PPP6R3/LRP5
locus influences lean
mass in children of different ethnic background
and highlights pleiotropic effects on muscle-bone
interactions.
M. C. Medina Gomez, D. H. M. Heppe, K.
Estrada, J. Van Meurs, A. Hofman, Y.-H. Hsu, D. Karasik,
V. W. V. Jaddoe, M. C. Zillikens, A. G. Uitterlinden, F.
Rivadeneira, GEFOS Consortium.
1335
T Examining the interaction effect of SNPs
associated with urinary bladder cancer.
H. Schwender,
S. Selinski, T. Stöcker, M. Blaszkewicz, R. Marchan, K.
Ickstadt, K. Golka, J. Hengstler.
1336
F Multivariate modeling for a more powerful
genetic association analysis.
S. Eyheramendy, C. Meza.
1337
W Random-effects model for massive meta
analysis in genome-wide association study with